PMC:7161517 / 162-316 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":22,"end":26},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"s-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation observed in SARS-CoV was pre"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":5,"end":13},"obj":"Disease"},{"id":"T4","span":{"begin":27,"end":36},"obj":"Disease"},{"id":"T5","span":{"begin":138,"end":146},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"s-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation observed in SARS-CoV was pre"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":22,"end":26},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"s-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation observed in SARS-CoV was pre"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":63,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"s-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation observed in SARS-CoV was pre"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T6","span":{"begin":5,"end":15},"obj":"SP_7"},{"id":"T7","span":{"begin":63,"end":94},"obj":"PG_10;PR:000003622"},{"id":"T8","span":{"begin":96,"end":100},"obj":"G_3;PG_10;PR:000003622"},{"id":"T9","span":{"begin":112,"end":125},"obj":"GO:0065007"},{"id":"T10","span":{"begin":138,"end":146},"obj":"SP_10"},{"id":"T26357","span":{"begin":5,"end":15},"obj":"SP_7"},{"id":"T3432","span":{"begin":63,"end":94},"obj":"PG_10;PR:000003622"},{"id":"T99057","span":{"begin":96,"end":100},"obj":"G_3;PG_10;PR:000003622"},{"id":"T53282","span":{"begin":112,"end":125},"obj":"GO:0065007"},{"id":"T31949","span":{"begin":138,"end":146},"obj":"SP_10"}],"text":"s-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation observed in SARS-CoV was pre"}

{"project":"LitCovid-PubTator","denotations":[{"id":"21","span":{"begin":63,"end":94},"obj":"Gene"},{"id":"22","span":{"begin":96,"end":100},"obj":"Gene"},{"id":"32","span":{"begin":5,"end":15},"obj":"Species"},{"id":"33","span":{"begin":138,"end":146},"obj":"Species"},{"id":"36","span":{"begin":27,"end":36},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Gene:59272"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Gene:59272"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:2697049"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Tax:694009"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s-2 (SARS-CoV-2) host cell infection is mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation observed in SARS-CoV was pre"}